Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novamind Inc. (NM.CN)

Novamind Inc. (NM.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 42,774
  • Shares Outstanding, K 41,528
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NM.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings -1.71 on 03/31/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Care

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.870 +19.54%
on 07/09/21
1.220 -14.75%
on 07/14/21
+0.030 (+2.97%)
since 06/23/21
3-Month
0.870 +19.54%
on 07/09/21
1.500 -30.67%
on 05/13/21
-0.110 (-9.57%)
since 04/23/21

Most Recent Stories

More News
Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

Aims to increase visibility and facilitate investment for United States investors

OTCM : 46.0000 (-1.08%)
NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial

Cedar Clinical Research to Host Phase IIb Trial for a Novel PTSD Treatment

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Launches Psychedelic Therapy Frontiers Podcast

Aimed at an audience of psychedelic medicine researchers and clinicians

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer

Led first-of-its-kind study of group psilocybin therapy for cancer patients with depressionCo-Investigator on a study to evaluate ketamine as a treatment for opioid use disorderWill lead Novamind's clinical...

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company

TORONTO, ON / ACCESSWIRE / June 17, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announces...

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021

Novamind to be featured in panel discussions on the disruptive potential of psychedelic treatments

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers

Novamind and the Wholeness Center to launch clinical offering in Utah and Colorado

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Reports Fiscal Q3 Financial Results and Operating Highlights

Revenue of $1,846,132 for Fiscal Q3 2021, +43% quarter-over-quarterAnnounced doubling of clinic network by September 2021Forecasting 65,000 clinic visits in 2021, +225% year-over-year

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
BNO : 19.08 (+0.69%)
Novamind Opens Client Care Center to Support High Demand for Treatments

Invests in care support systems to facilitate rapid expansion

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)
Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics

New clinics represent the first phase of Novamind's national expansion strategy

NM.CN : 1.040 (+0.97%)
NVMDF : 0.8180 (+0.99%)

Key Turning Points

3rd Resistance Point 1.083
2nd Resistance Point 1.067
1st Resistance Point 1.053
Last Price 1.040
1st Support Level 1.023
2nd Support Level 1.007
3rd Support Level 0.993

See More

52-Week High 2.340
Fibonacci 61.8% 1.778
Fibonacci 50% 1.605
Fibonacci 38.2% 1.432
Last Price 1.040
52-Week Low 0.870

See More

Business Summary

Novamind Inc is a mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar